Physician
Obstetrics & Gynecology
Dr. Ronald E. Hempling, MD
|
|
Give Review
Dr. Ronald E. Hempling works in the field of Obstetrics & Gynecology. He went to University of Oklahoma College of Medicine. He over the years received 1 awards: "Fellow (FACOG)". Ronald Hempling is also a published doctor. He has 57 publication published. The most recent publication is: Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma.
Publications
- Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-bas...
- Paclitaxel and cisplatin combination chemotherapy in recurrent epithelial Ovarian cancer.
- Pretreatment transperitoneal laparoscopic staging pelvic and paraaortic lymphadenectomy in large (> or = 5 cm) stage IB2 cervical carcinoma: report of a pilot study.
- The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical car...
- Hormone replacement therapy as a risk factor for epithelial Ovarian cancer: results of a case-control study.
- Second-look laparotomy in advanced Ovarian cancer: a critical assessment of morbidity and impact on survival.
- Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal ...
- Estrogen replacement therapy following oophorectomy in women with a family history of Ovarian cancer.
- The inferior gluteal flap in the difficult vulvar and perineal reconstruction.
- Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cispla...
- Laparoscopic-assisted application of interstitial brachytherapy for locally advanced cervical carcinoma: results of a pilot study.
- Prospective sequential trials of induction weekly cisplatin followed by monthly cisplatin, doxorubicin, cyclophosphamide and paclitaxel and cisplatin in optimal (< or ...
- Five-year survival after second-line cisplatin-based intraperitoneal chemotherapy for advanced Ovarian cancer.
- Remarkable response of primary squamous cell carcinoma of the ovary to paclitaxel and cisplatin.
- The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
- Importance of lymph node metastases in primary peritoneal carcinoma.
- Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortality.
- Stage I adenocarcinoma of the cervix: does lesion size affect treatment options and prognosis?
- Progesterone receptor status is a significant prognostic variable of progression-free survival in advanced epithelial Ovarian cancer.
- Complications related to indwelling caval catheters on a gynecologic oncology service.
- Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive Ovarian cancer.
- Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma.
- Effects of IL-12 on human Ovarian tumors engrafted into SCID mice.
- Characterization of human Ovarian carcinomas in a SCID mouse model.
- Perineal talc exposure and subsequent epithelial Ovarian cancer: a case-control study.
- Effective management of pelvic lymphocysts by laparoscopic marsupialization.
- Laparoscopic management of women with a family history of Ovarian cancer.
- Analysis of failed and complicated laparoscopy on a gynecologic oncology service.
- Laparoscopic surgery in obese women.
- Flt-3 ligand inhibits growth of human Ovarian tumors engrafted in severe combined immunodeficient mice.
- A prospective trial of progesterone therapy for malignant peritoneal cytology in patients with endometrial carcinoma.
- Five-year survival for stage IC or stage I grade 3 epithelial Ovarian cancer treated with cisplatin-based chemotherapy.
- Leukemia following cisplatin-based chemotherapy for Ovarian carcinoma at Roswell Park.
- Cisplatin-based chemotherapy for stage II Ovarian adenocarcinoma: a preliminary report.
- A prospective trial of postoperative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial ...
- Neoplasms.
- Rectal J-pouch reservoir to decrease the frequency of tenesmus and defecation in low coloproctostomy.
- Rectal J pouch reservoir to decrease the frequency of tenesmus and defecation in low coloproctostomy.
- Pregnancy-associated group B streptococcal endocarditis: a report of two fatal cases.
- Antibiotic therapy for the Bacteroidaceae in post-cesarean section infections.
- Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sar...
- Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery.
- Response to Taxol chemotherapy in resistant Ovarian carcinoma.
- Lack of activity of 5-fluorouracil plus mitomycin-C as salvage therapy in cisplatin-resistant epithelial Ovarian cancer: results of a phase II trial.
- Tumor markers in epithelial Ovarian cancer. Clinical applications.
- Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ...
- Immunoscintigraphy using 111InCyt103 prior to second look laparotomy in Ovarian cancer. A pilot study.
- Pregnancy coexisting with serous papillary adenocarcinoma involving both uterus and ovary.
- Vulvar carcinoma with 0.5 mm of invasion and associated inguinal lymph node metastasis.
- Intraoperative orthovoltage radiation therapy in the treatment of recurrent gynecologic malignancies.
- Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus.
- Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced Ovarian cancer.
- A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma.
- The addition of etoposide and ifosfamide to cisplatin as second line therapy in Ovarian carcinoma.
- Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
- Comparison of Ifosfamide versus cyclophosphamide in combination with Cisplatin and Doxorubicin (adriamycin), as first-line therapy for advanced epithelial Ovarian-canc...
Schools
University Of Oklahoma College Of Medicine
University Hospital
Roswell Park Cancer Institute
Union Memorial Hospital
Procedures Preformed
- Gynecologic Cancer Screening
Conditions Treated
- Ovarian Cancer
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACOG)
Education
-
University of Oklahoma Health Sciences Center -
University Hospital & Clinics -
University of Oklahoma College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Timothy B. McGuinness, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marian D. Damewood, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracey P. Grim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin C. Wolverton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William M. Unwin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stacey L. Woodard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marsha D. Bornt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brandi N. Ring, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natasha A. Rodney, MD |
|
|
Dr. Kristopher S. Lybarger, DO
This Doctor is OpenDoctor Recommended.
|